In:
Glia, Wiley, Vol. 61, No. 11 ( 2013-11), p. 1832-1847
Abstract:
Deficiency of the major constituent of central nervous system (CNS) myelin, proteolipid protein (PLP), causes axonal pathology in spastic paraplegia type‐2 patients and in Plp1 null ‐mice but is compatible with almost normal myelination. These observations led us to speculate that PLP's role in myelination may be partly compensated for by other tetraspan proteins. Here, we demonstrate that the abundance of the structurally related tetraspanin‐2 (TSPAN2) is highly increased in CNS myelin of Plp1 null ‐mice. Unexpectedly, Tspan2 null ‐mutant mice generated by homologous recombination in embryonic stem cells displayed low‐grade activation of astrocytes and microglia in white matter tracts while they were fully myelinated and showed no signs of axonal degeneration. To determine overlapping functions of TSPAN2 and PLP, Tspan2 null * Plp1 null double‐mutant mice were generated. Strikingly, the activation of astrocytes and microglia was strongly enhanced in Tspan2 null * Plp1 null double‐mutants compared with either single‐mutant, but the levels of dysmyelination and axonal degeneration were not increased. In this model, glial activation is thus unlikely to be caused by axonal pathology, and vice versa does not potentiate axonal degeneration. Our results support the concept that multiple myelin proteins have distinct roles in the long‐term preservation of a healthy CNS, rather than in myelination per se . GLIA 2013;61:1832–1847
Type of Medium:
Online Resource
ISSN:
0894-1491
,
1098-1136
Language:
English
Publisher:
Wiley
Publication Date:
2013
detail.hit.zdb_id:
639414-0
detail.hit.zdb_id:
1474828-9
SSG:
12
